SciFluor Life Sciences

company

About

SciFluor Life Sciences develops fluorination technologies that improve drug properties such as metabolic stability and potency.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$30M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

SciFluor Life Sciences is an Allied Minds funded company with a late-stage fluorination technology that improves drug properties such as metabolic stability, potency, bioavailability, and blood-brain-barrier penetration. The company's late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor's technology enables end-stage or any-stage fluorination of a wide variety of organic compounds.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
SciFluor Life Sciences has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Apr 21, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 21, 2015 Series B $30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
SciFluor Life Sciences is funded by 1 investors. Invesco are the most recent investors.
Investor Name Lead Investor Funding Round
Invesco Series B